STRATA CRITICAL MEDICAL, INC. (SRTA) Scorecard
- 2026-Q2: Total return Win; Revenue growth Win; EPS growth Lose.
- 2026-Q1: Total return Lose; Revenue growth Win; EPS growth Lose.
- 2025-Q4: Total return Lose; Revenue growth Lose; EPS growth Lose.
- 2025-Q3: Total return Win; Revenue growth Lose; EPS growth Lose.
17/120
All 120 Win/Lose results shown below
Every strict quarterly win earns 1 point. A loss, tie, or unavailable scoring value earns 0.
Trailing 1 year (4 quarters): 4 wins, 8 lossesLast fetched: 4 Sept 2026
Complete point ledger
Each cell identifies the missing side explicitly.
| Quarter | Total return | Revenue growth | EPS growth |
|---|---|---|---|
| 2026-Q22/3 |
WinSRTA / S&P 26.08% / 15.20% |
WinSRTA / S&P 66.75% / 15.00% |
LoseSRTA / S&P -304.17% / 50.40% |
| 2026-Q11/3 |
LoseSRTA / S&P -13.10% / -4.33% |
WinSRTA / S&P 29.62% / 11.30% |
LoseSRTA / S&P -264.71% / 27.70% |
| 2025-Q40/3 |
LoseSRTA / S&P -4.94% / 2.65% |
LoseSRTA / S&P 2.73% / 9.00% |
LoseSRTA / S&P -236.11% / 13.40% |
| 2025-Q31/3 |
WinSRTA / S&P 25.56% / 8.12% |
LoseSRTA / S&P -17.86% / 4.61% |
LoseSRTA / S&P -170.00% / 13.45% |
| 2025-Q21/3 |
WinSRTA / S&P 47.62% / 10.94% |
LoseSRTA / S&P -35.60% / 4.83% |
LoseSRTA / S&P -64.18% / 10.63% |
| 2025-Q10/3 |
LoseSRTA / S&P -35.76% / -4.27% |
LoseSRTA / S&P -23.80% / 4.98% |
LoseSRTA / S&P -50.72% / 10.57% |
| 2024-Q41/3 |
WinSRTA / S&P 44.56% / 2.41% |
LoseSRTA / S&P -14.78% / 5.25% |
LoseSRTA / S&P -53.25% / 6.15% |
| 2024-Q31/3 |
LoseSRTA / S&P -15.52% / 5.89% |
LoseSRTA / S&P -5.95% / 5.89% |
WinSRTA / S&P 34.62% / 6.11% |
| 2024-Q22/3 |
WinSRTA / S&P 22.11% / 4.28% |
WinSRTA / S&P 25.39% / 5.38% |
LoseSRTA / S&P 3.08% / 5.12% |
| 2024-Q12/3 |
LoseSRTA / S&P -19.26% / 10.56% |
WinSRTA / S&P 40.46% / 5.71% |
WinSRTA / S&P 81.58% / 5.59% |
| 2023-Q43/3 |
WinSRTA / S&P 36.29% / 11.69% |
WinSRTA / S&P 54.11% / 6.81% |
WinSRTA / S&P 92.50% / 7.78% |
| 2023-Q30/3 |
LoseSRTA / S&P -34.26% / -3.27% |
LoseSRTA / S&P SRTA unavailable / 7.52% |
LoseSRTA / S&P SRTA unavailable / -5.03% |
| 2023-Q21/3 |
WinSRTA / S&P 16.57% / 8.74% |
LoseSRTA / S&P SRTA unavailable / 9.50% |
LoseSRTA / S&P SRTA unavailable / -8.57% |
| 2023-Q10/3 |
LoseSRTA / S&P -5.59% / 7.50% |
LoseSRTA / S&P SRTA unavailable / 10.77% |
LoseSRTA / S&P SRTA unavailable / -15.69% |
| 2022-Q40/3 |
LoseSRTA / S&P -11.17% / 7.56% |
LoseSRTA / S&P SRTA unavailable / 11.88% |
LoseSRTA / S&P SRTA unavailable / -17.99% |
| 2022-Q30/3 |
LoseSRTA / S&P -9.64% / -4.88% |
LoseSRTA / S&P SRTA unavailable / 13.47% |
LoseSRTA / S&P SRTA unavailable / -1.41% |
| 2022-Q20/3 |
LoseSRTA / S&P -47.47% / -16.10% |
LoseSRTA / S&P SRTA unavailable / 13.71% |
LoseSRTA / S&P SRTA unavailable / 11.04% |
| 2022-Q11/3 |
WinSRTA / S&P -3.85% / -4.60% |
LoseSRTA / S&P SRTA unavailable / 15.97% |
LoseSRTA / S&P SRTA unavailable / 42.23% |
| 2021-Q40/3 |
LoseSRTA / S&P -15.10% / 11.03% |
LoseSRTA / S&P SRTA unavailable / 15.00% |
LoseSRTA / S&P SRTA unavailable / 96.40% |
| 2021-Q30/3 |
LoseSRTA / S&P -0.95% / 0.58% |
LoseSRTA / S&P SRTA unavailable / 10.77% |
LoseSRTA / S&P SRTA unavailable / 69.42% |
| 2021-Q20/3 |
LoseSRTA / S&P 2.04% / 8.55% |
LoseSRTA / S&P SRTA unavailable / 6.58% |
LoseSRTA / S&P SRTA unavailable / 51.81% |
| 2021-Q10/3 |
LoseSRTA / S&P -7.13% / 6.17% |
LoseSRTA / S&P SRTA unavailable / -1.06% |
LoseSRTA / S&P SRTA unavailable / 7.39% |
| 2020-Q40/3 |
LoseSRTA / S&P 10.25% / 12.15% |
LoseSRTA / S&P SRTA unavailable / -3.72% |
LoseSRTA / S&P SRTA unavailable / -33.42% |
| 2020-Q30/3 |
LoseSRTA / S&P 0.80% / 8.93% |
LoseSRTA / S&P SRTA unavailable / -2.04% |
LoseSRTA / S&P SRTA unavailable / -27.10% |
| 2020-Q20/3 |
LoseSRTA / S&P 3.10% / 20.54% |
LoseSRTA / S&P SRTA unavailable / -0.46% |
LoseSRTA / S&P SRTA unavailable / -27.11% |
| 2020-Q11/3 |
WinSRTA / S&P -1.63% / -19.60% |
LoseSRTA / S&P SRTA unavailable / 3.47% |
LoseSRTA / S&P SRTA unavailable / -14.75% |
| 2019-Q40/3 |
LoseSRTA / S&P SRTA unavailable / 9.07% |
LoseSRTA / S&P SRTA unavailable / 5.36% |
LoseSRTA / S&P SRTA unavailable / 2.99% |
| 2019-Q30/3 |
LoseSRTA / S&P SRTA unavailable / 1.70% |
LoseSRTA / S&P SRTA unavailable / 5.02% |
LoseSRTA / S&P SRTA unavailable / 0.21% |
| 2019-Q20/3 |
LoseSRTA / S&P SRTA unavailable / 4.30% |
LoseSRTA / S&P SRTA unavailable / 6.64% |
LoseSRTA / S&P SRTA unavailable / 8.65% |
| 2019-Q10/3 |
LoseSRTA / S&P SRTA unavailable / 13.65% |
LoseSRTA / S&P SRTA unavailable / 8.12% |
LoseSRTA / S&P SRTA unavailable / 14.29% |
| 2018-Q40/3 |
LoseSRTA / S&P SRTA unavailable / -13.52% |
LoseSRTA / S&P SRTA unavailable / 9.05% |
LoseSRTA / S&P SRTA unavailable / 18.23% |
| 2018-Q30/3 |
LoseSRTA / S&P SRTA unavailable / 7.71% |
LoseSRTA / S&P SRTA unavailable / 10.21% |
LoseSRTA / S&P SRTA unavailable / 19.06% |
| 2018-Q20/3 |
LoseSRTA / S&P SRTA unavailable / 3.43% |
LoseSRTA / S&P SRTA unavailable / 9.03% |
LoseSRTA / S&P SRTA unavailable / 14.46% |
| 2018-Q10/3 |
LoseSRTA / S&P SRTA unavailable / -0.76% |
LoseSRTA / S&P SRTA unavailable / 7.68% |
LoseSRTA / S&P SRTA unavailable / 12.46% |
| 2017-Q40/3 |
LoseSRTA / S&P SRTA unavailable / 6.64% |
LoseSRTA / S&P SRTA unavailable / 7.03% |
LoseSRTA / S&P SRTA unavailable / 13.82% |
| 2017-Q30/3 |
LoseSRTA / S&P SRTA unavailable / 4.48% |
LoseSRTA / S&P SRTA unavailable / 5.68% |
LoseSRTA / S&P SRTA unavailable / 17.57% |
| 2017-Q20/3 |
LoseSRTA / S&P SRTA unavailable / 3.09% |
LoseSRTA / S&P SRTA unavailable / 4.83% |
LoseSRTA / S&P SRTA unavailable / 17.74% |
| 2017-Q10/3 |
LoseSRTA / S&P SRTA unavailable / 6.07% |
LoseSRTA / S&P SRTA unavailable / 3.67% |
LoseSRTA / S&P SRTA unavailable / 13.32% |
| 2016-Q40/3 |
LoseSRTA / S&P SRTA unavailable / 3.82% |
LoseSRTA / S&P SRTA unavailable / 2.09% |
LoseSRTA / S&P SRTA unavailable / 7.05% |
| 2016-Q30/3 |
LoseSRTA / S&P SRTA unavailable / 3.85% |
LoseSRTA / S&P SRTA unavailable / 0.20% |
LoseSRTA / S&P SRTA unavailable / -3.15% |
Dividend-reinvested, split-adjusted total return
1Y · 2025-08-29 to 2026-08-27
| Metric | SRTA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | 41.19% | 20.78% |
| Annualized return | 41.19% | 20.78% |
5Y · 2021-09-01 to 2026-08-27
| Metric | SRTA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -30.28% | 83.14% |
| Annualized return | -6.96% | 12.86% |
10Y · 2019-11-05 to 2026-08-27
| Metric | SRTA total return | S&P 500 Total Return Index |
|---|---|---|
| Total return | -36.72% | 319.30% |
| Annualized return | -4.47% | 15.41% |
Calculation rules
- window
- Latest 40 completed benchmark quarters; unavailable issuer evidence remains visible and scores 0.
- return Basis
- Issuer adjusted close reinvests distributions and normalizes splits; the S&P 500 Total Return Index is the direct benchmark.
- point Rule
- Strict same-quarter win = 1. Loss, tie or unavailable evidence = 0. No partial or subjective points.
- frequency
- Quarter endpoints only.
- fundamentals
- Trailing-four-quarter issuer revenue and EPS growth use the issuer's normalized government-filed facts.
- non Scoring
Snapshot captured 2026-09-04.
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DocGo Inc. (DCGO) | United States | $0.034B | -0.25 |
| VSEE HEALTH, INC. (VSEE) | United States | $0.003B | |
| Agape ATP Corp (ATPC) | $0.002B | ||
| InnovAge Holding Corp. (INNV) | United States | $1.206B | -635.60 |
| Omada Health, Inc. (OMDA) | United States | $1.207B | 309.08 |
| U S PHYSICAL THERAPY INC /NV (USPH) | United States | $1.251B | 32.48 |
| Pennant Group, Inc. (PNTG) | United States | $1.386B | 39.84 |
| Privia Health Group, Inc. (PRVA) | United States | $2.477B | 115.52 |
| GeneDx Holdings Corp. (WGS) | United States | $2.638B | -19.23 |
| LifeStance Health Group, Inc. (LFST) | United States | $4.510B | 80.86 |